CClinicalTrials.gg
RecruitingNCT07090512Updated Jul 29, 2025

Multimodal Ultrasound in DBD Kidneys for Predicting Early Postoperative Renal Insufficiency Risk

An observational study in Occurrence of Renal Dysfunction (GFR ≤ 60mL/(Min·1.73m2)) in Renal Transplant Recipients Within One Year After Kidney Transplantation, sponsored by Bei Wang. Recruiting at 1 site in China. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-29.

Sponsored by Bei Wang · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2025, 9 months ago, but the record still lists the study as recruiting.
  • Started Jan 2025; still recruiting 1 year 9 months later.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
27
Ages
18 Years and older
Sex
All
01

Study summary

The objective of this observational study is to investigate the multimodal ultrasound parameters of kidneys from brain-dead organ donors prior to donation, in order to construct a predictive model for assessing the risk of early transplant renal dysfunction after kidney transplantation in recipients.

The primary question this study aims to address is:

Can multimodal ultrasound data from brain-dead organ donor kidneys accurately predict early post-transplant renal dysfunction?

Ultrasonography, as a routine examination before organ donation, will be utilized, and the study results will be concluded within one year after participation in this study.

02

Conditions studied

  • Occurrence of Renal Dysfunction (GFR ≤ 60mL/(Min·1.73m2)) in Renal Transplant Recipients Within One Year After Kidney Transplantation
03

In context

Lead sponsor

This is the only study on the registry with Bei Wang as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Brain-deceased organ donors and their matched kidney transplant recipients at the First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital of Shandong Province).

Inclusion criteria

  • Recipient Study Participants Age ≥18 years;

Underwent allogeneic kidney transplantation at this hospital;

Signed informed consent form.

Donor Study Participants Brain-deceased organ donors;

Completed organ donation at the First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital of Shandong Province);

Brain death criteria:

Deep coma (with clear etiology and exclusion of reversible causes);

Absence of brainstem reflexes;

No spontaneous respiration;

Confirmed by at least two confirmatory tests (SLSEP, EEG, TCD), with re-evaluation 12 hours after the initial determination.

Standard Criteria Donor (SCD):

  • Age 10-39 years;

    • Cause of death unrelated to cerebrovascular disease;

      • Serum creatinine \<133 μmol/L;

        • No history of hypertension.

Expanded Criteria Donor (ECD):

  • Age >60 years; OR

    ② Age 50-59 years with two of the following three criteria:

  • Cause of death related to cerebrovascular disease;

    • Serum creatinine \<133 μmol/L;

      • History of hypertension.

Signed informed consent form.

Exclusion criteria

Exclusion Criteria:

  • Recipient Study Participants Patients with multiple kidney transplants;

Patients with follow-up duration less than 1 year;

Patients experiencing irreversible loss of graft function due to postoperative complications (e.g., rejection, thrombosis, anastomotic stenosis, infection).

Donor Study Participants Severe primary renal diseases (e.g., hypertensive nephropathy, diabetic nephropathy, renal tumors);

Cases with unavailable ultrasound imaging data:

Excessive respiratory motion in donors;

Obesity or other factors affecting imaging quality.

Individuals with allergic predisposition.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
27 participants (estimated)
Patient registry
No

Interventions

  • Diagnostic testMultimodal Ultrasound

    Multimodal ultrasound data collection will be conducted on all organ donors meeting the research criteria.

06

What researchers measure

Primary outcomes

  1. chronic allograft dysfunction

    Occurrence of chronic allograft dysfunction (GFR ≤ 60mL/(min·1.73m2)) in renal transplant recipients within one year after kidney transplantation.

    Time frame: Development of chronic allograft dysfunction within one year following kidney transplantation.

07

Study locations

1 of 1 sites recruiting
  • The First Affiliated Hospital of Shandong First Medical University
    Jinan, Shandong 250000, China
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07090512
Lead sponsor
Bei Wang
Responsible party
Bei Wang (Chief Physician, Qianfoshan Hospital) — Sponsor-investigator
First posted
Jul 29, 2025
Start date
Jan 1, 2025
Primary completion
Dec 31, 2025 (estimated)
Completion
Mar 31, 2026 (estimated)
Last update
Jul 29, 2025

Study contacts

Bei Wang
Contact
wangbei1224@126.com
(86)+18853182401

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion